How Variable are Interstate Prevalence Rates of Learning Disabilities and other Special Education Categories? A Longitudinal Comparison von Hallahan, Daniel P., Keller, Clayton E., Martinez, Elizabeth A., Byrd, E. Stephen, Gelman, Jennifer A., Fan, Xitao

Volltext

Educating and Involving Parents in the Response to Intervention Process: The School's Important Role von Byrd, E. Stephen

Volltext

India, Families, and a Special School von Byrd, E. Stephen

Volltext

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging von Amin, Mahul B., Greene, Frederick L., Edge, Stephen B., Compton, Carolyn C., Gershenwald, Jeffrey E., Brookland, Robert K., Meyer, Laura, Gress, Donna M., Byrd, David R., Winchester, David P.

Volltext

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma von Hegde, Meenakshi, Joseph, Sujith K., Pashankar, Farzana, DeRenzo, Christopher, Sanber, Khaled, Navai, Shoba, Byrd, Tiara T., Hicks, John, Xu, Mina L., Gerken, Claudia, Kalra, Mamta, Robertson, Catherine, Zhang, Huimin, Shree, Ankita, Mehta, Birju, Dakhova, Olga, Salsman, Vita S., Grilley, Bambi, Gee, Adrian, Dotti, Gianpietro, Heslop, Helen E., Brenner, Malcolm K., Wels, Winfried S., Gottschalk, Stephen, Ahmed, Nabil

Volltext

Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study von Dutton, Philip J, Warrander, Lynne K, Roberts, Stephen A, Bernatavicius, Giovanna, Byrd, Louise M, Gaze, David, Kroll, Josh, Jones, Rebecca L, Sibley, Colin P, Frøen, J Frederik, Heazell, Alexander E P

Volltext

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia von Brown, Jennifer R., Byrd, John C., Coutre, Steven E., Benson, Don M., Flinn, Ian W., Wagner-Johnston, Nina D., Spurgeon, Stephen E., Kahl, Brad S., Bello, Celeste, Webb, Heather K., Johnson, Dave M., Peterman, Sissy, Li, Daniel, Jahn, Thomas M., Lannutti, Brian J., Ulrich, Roger G., Yu, Albert S., Miller, Langdon L., Furman, Richard R.

Volltext

An Unusual Topological Structure of the HIV-1 Rev Response Element von Fang, Xianyang, Wang, Jinbu, O’Carroll, Ina P., Mitchell, Michelle, Zuo, Xiaobing, Wang, Yi, Yu, Ping, Liu, Yu, Rausch, Jason W., Dyba, Marzena A., Kjems, Jørgen, Schwieters, Charles D., Seifert, Soenke, Winans, Randall E., Watts, Norman R., Stahl, Stephen J., Wingfield, Paul T., Byrd, R. Andrew, Le Grice, Stuart F.J., Rein, Alan, Wang, Yun-Xing

Volltext

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia von Byrd, John C, Brown, Jennifer R, O'Brien, Susan, Barrientos, Jacqueline C, Kay, Neil E, Reddy, Nishitha M, Coutre, Steven, Tam, Constantine S, Mulligan, Stephen P, Jaeger, Ulrich, Devereux, Steve, Barr, Paul M, Furman, Richard R, Kipps, Thomas J, Cymbalista, Florence, Pocock, Christopher, Thornton, Patrick, Caligaris-Cappio, Federico, Robak, Tadeusz, Delgado, Julio, Schuster, Stephen J, Montillo, Marco, Schuh, Anna, de Vos, Sven, Gill, Devinder, Bloor, Adrian, Dearden, Claire, Moreno, Carol, Jones, Jeffrey J, Chu, Alvina D, Fardis, Maria, McGreivy, Jesse, Clow, Fong, James, Danelle F, Hillmen, Peter

Volltext

A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL) von Kahl, Brad S., Spurgeon, Stephen E., Furman, Richard R., Flinn, Ian W., Coutre, Steven E., Brown, Jennifer R., Benson, Don M., Byrd, John C., Peterman, Sissy, Cho, Yoonjin, Yu, Albert, Godfrey, Wayne R., Wagner-Johnston, Nina D.

Volltext

Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma von Hegde, Meenakshi, Corder, Amanda, Chow, Kevin KH, Mukherjee, Malini, Ashoori, Aidin, Kew, Yvonne, Zhang, Yi Jonathan, Baskin, David S, Merchant, Fatima A, Brawley, Vita S, Byrd, Tiara T, Krebs, Simone, Wu, Meng Fen, Liu, Hao, Heslop, Helen E, Gottachalk, Stephen, Yvon, Eric, Ahmed, Nabil

Volltext

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma von Flinn, Ian W., Kahl, Brad S., Leonard, John P., Furman, Richard R., Brown, Jennifer R., Byrd, John C., Wagner-Johnston, Nina D., Coutre, Steve E., Benson, Don M., Peterman, Sissy, Cho, Yoonjin, Webb, Heather K., Johnson, David M., Yu, Albert S., Ulrich, Roger G., Godfrey, Wayne R., Miller, Langdon L., Spurgeon, Stephen E.

Volltext

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis von Kunkle, Brian W, Schmidt, Michael, Klein, Hans-Ulrich, Naj, Adam C, Hamilton-Nelson, Kara L, Larson, Eric B, Evans, Denis A, De Jager, Phil L, Crane, Paul K, Buxbaum, Joe D, Ertekin-Taner, Nilufer, Barnes, Lisa L, Fallin, M. Daniele, Manly, Jennifer J, Go, Rodney C. P, Obisesan, Thomas O, Kamboh, M. Ilyas, Bennett, David A, Hall, Kathleen S, Goate, Alison M, Foroud, Tatiana M, Martin, Eden R, Wang, Li-San, Byrd, Goldie S, Farrer, Lindsay A, Haines, Jonathan L, Schellenberg, Gerard D, Mayeux, Richard, Pericak-Vance, Margaret A, Reitz, Christiane, Graff-Radford, Neill R, Martinez, Izri, Ayodele, Temitope, Logue, Mark W, Cantwell, Laura B, Jean-Francois, Melissa, Kuzma, Amanda B, Adams, L.D, Vance, Jeffery M, Cuccaro, Michael L, Chung, Jaeyoon, Mez, Jesse, Lunetta, Kathryn L, Jun, Gyungah R, Lopez, Oscar L, Hendrie, Hugh C, Reiman, Eric M, Kowall, Neil W, Leverenz, James B, Small, Scott A, Levey, Allan I, Golde, Todd E, Saykin, Andrew J, Starks, Takiyah D, Albert, Marilyn S, Hyman, Bradley T, Petersen, Ronald C, Sano, Mary, Wisniewski, Thomas, Vassar, Robert, Kaye, Jeffrey A, Henderson, Victor W, DeCarli, Charles, LaFerla, Frank M, Brewer, James B, Miller, Bruce L, Swerdlow, Russell H, Van Eldik, Linda J, Paulson, Henry L, Trojanowski, John Q, Chui, Helena C, Rosenberg, Roger N, Craft, Suzanne, Grabowski, Thomas J, Asthana, Sanjay, Morris, John C, Strittmatter, Stephen M, Kukull, Walter A

Volltext

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis von Brown, Jennifer R., Moslehi, Javid, Ewer, Michael S., O'Brien, Susan M., Ghia, Paolo, Cymbalista, Florence, Shanafelt, Tait D., Fraser, Graeme, Rule, Simon, Coutre, Steven E., Dilhuydy, Marie‐Sarah, Cramer, Paula, Jaeger, Ulrich, Dreyling, Martin, Byrd, John C., Treon, Steven, Liu, Emily Y., Chang, Stephen, Bista, Amulya, Vempati, Rama, Boornazian, Lisa, Valentino, Rudolph, Reddy, Vijay, Mahler, Michelle, Yang, Huiying, Graef, Thorsten, Burger, Jan A.

Volltext

SARS-CoV-2 infection of the oral cavity and saliva von Huang, Ni, Pérez, Paola, Kato, Takafumi, Mikami, Yu, Okuda, Kenichi, Gilmore, Rodney C., Conde, Cecilia Domínguez, Gasmi, Billel, Stein, Sydney, Beach, Margaret, Pelayo, Eileen, Maldonado, Jose O., Lafont, Bernard A., Jang, Shyh-Ing, Nasir, Nadia, Padilla, Ricardo J., Murrah, Valerie A., Maile, Robert, Lovell, William, Wallet, Shannon M., Bowman, Natalie M., Meinig, Suzanne L., Wolfgang, Matthew C., Choudhury, Saibyasachi N., Novotny, Mark, Aevermann, Brian D., Scheuermann, Richard H., Cannon, Gabrielle, Anderson, Carlton W., Lee, Rhianna E., Marchesan, Julie T., Bush, Mandy, Freire, Marcelo, Kimple, Adam J., Herr, Daniel L., Rabin, Joseph, Grazioli, Alison, Das, Sanchita, French, Benjamin N., Pranzatelli, Thomas, Chiorini, John A., Kleiner, David E., Pittaluga, Stefania, Hewitt, Stephen M., Burbelo, Peter D., Chertow, Daniel, Frank, Karen, Lee, Janice, Boucher, Richard C., Teichmann, Sarah A., Warner, Blake M., Byrd, Kevin M.

Volltext

A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia von Byrd, John C., Pagel, John M., Awan, Farrukh T., Forero, Andres, Flinn, Ian W., Deauna-Limayo, Delva P., Spurgeon, Stephen E., Andritsos, Leslie A., Gopal, Ajay K., Leonard, John P., Eisenfeld, Amy J., Bannink, Jeannette E., Stromatt, Scott C., Furman, Richard R.

Volltext

A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma von McMichael, Elizabeth L, Benner, Brooke, Atwal, Lakhvir S, Courtney, Nicholas B, Mo, Xiaokui, Davis, Melanie E, Campbell, Amanda R, Duggan, Megan C, Williams, Kallan, Martin, Kyle, Levine, Kala, Olaverria Salavaggione, Gonzalo N, Noel, Tiffany, Ganju, Akaansha, Uppati, Sarvani, Paul, Bonnie, Olencki, Thomas, Teknos, Theodoros N, Savvides, Panos, Tridandapani, Susheela, Byrd, John C, Caligiuri, Michael A, Liu, Stephen V, Carson, 3rd, William E

Volltext

Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia von Solman, Isabelle G., Blum, Lisa K., Hoh, Hana Y., Kipps, Thomas J., Burger, Jan A., Barrientos, Jacqueline C., O’Brien, Susan, Mulligan, Stephen P., Kay, Neil E., Hillmen, Peter, Byrd, John C., Lal, Indu D., Dean, James P., Mongan, Ann

Volltext

An interaction between early threat exposure and the oxytocin receptor in females: Disorder-specific versus general risk for psychopathology and social–emotional mediators von Byrd, Amy L., Tung, Irene, Manuck, Stephen D., Vine, Vera, Horner, Michelle, Hipwell, Alison E., Stepp, Stephanie D.

Volltext

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy von Grada, Zakaria, Hegde, Meenakshi, Byrd, Tiara, Shaffer, Donald R, Ghazi, Alexia, Brawley, Vita S, Corder, Amanda, Schönfeld, Kurt, Koch, Joachim, Dotti, Gianpietro, Heslop, Helen E, Gottschalk, Stephen, Wels, Winfried S, Baker, Matthew L, Ahmed, Nabil

Volltext